{"id":739853,"date":"2023-03-14T08:43:37","date_gmt":"2023-03-14T12:43:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"modified":"2023-03-14T08:43:37","modified_gmt":"2023-03-14T12:43:37","slug":"standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","title":{"rendered":"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"},"content":{"rendered":"
\n

SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health<\/em> \u2013 today announced that President and Chief Executive Officer Michael Egholm, PhD, will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 3:00 p.m. ET.<\/p>\n

The presentation will be webcast live and available on the Investor Relations page of the company\u2019s website at\u202fEvents & Presentations<\/a>. A recording of the webcast will be archived and available on the Standard BioTools\u2122 Investor Relations page at investors.standardbio.com<\/a>.\u00a0<\/p>\n

\n About Standard BioTools Inc.<\/strong>\u00a0<\/p>\n

Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health<\/em>.\u00a0Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. Learn more at standardbio.com or connect with us on Twitter\u00ae<\/a>, Facebook\u00ae<\/a>, LinkedIn<\/a>\u00ae, and YouTube<\/a>\u2122. Standard BioTools, the Standard BioTools logo, Fluidigm, the Fluidigm logo, and \u201cUnleashing tools to accelerate breakthroughs in human health\u201d are trademarks and\/or registered trademarks of\u00a0Standard BioTools Inc.\u00a0or its affiliates in\u00a0the United States\u00a0and\/or other countries. All other trademarks are the sole property of their respective owners. Standard BioTools\u00a0products are provided for\u00a0Research Use Only<\/strong>. Not for use in diagnostic procedures.<\/p>\n

\n Investor Contacts:<\/strong>\n <\/p>\n

Scott R. Greenstone, CFA
ir@standardbio.com<\/u><\/a>\u00a0<\/p>\n

Peter DeNardo\u00a0
415 389 6400\u00a0
ir@standardbio.com<\/u><\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 today announced that President and Chief Executive Officer Michael Egholm, PhD, will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 3:00 p.m. ET. The presentation will be webcast live and available on the Investor Relations page of the company\u2019s website at\u202fEvents & Presentations. A recording of the webcast will be archived and available on the Standard BioTools\u2122 Investor Relations page at investors.standardbio.com.\u00a0 About Standard BioTools Inc.\u00a0 Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a … <\/p>\n

Continue reading “Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-739853","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nStandard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 today announced that President and Chief Executive Officer Michael Egholm, PhD, will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 3:00 p.m. ET. The presentation will be webcast live and available on the Investor Relations page of the company\u2019s website at\u202fEvents & Presentations. A recording of the webcast will be archived and available on the Standard BioTools\u2122 Investor Relations page at investors.standardbio.com.\u00a0 About Standard BioTools Inc.\u00a0 Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a … Continue reading "Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T12:43:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\",\"datePublished\":\"2023-03-14T12:43:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"wordCount\":328,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"name\":\"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=\",\"datePublished\":\"2023-03-14T12:43:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_locale":"en_US","og_type":"article","og_title":"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc.\u00a0(Nasdaq:LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 today announced that President and Chief Executive Officer Michael Egholm, PhD, will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 3:00 p.m. ET. The presentation will be webcast live and available on the Investor Relations page of the company\u2019s website at\u202fEvents & Presentations. A recording of the webcast will be archived and available on the Standard BioTools\u2122 Investor Relations page at investors.standardbio.com.\u00a0 About Standard BioTools Inc.\u00a0 Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a … Continue reading \"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-14T12:43:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum","datePublished":"2023-03-14T12:43:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"wordCount":328,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","name":"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=","datePublished":"2023-03-14T12:43:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NSM1NDU5NjU3IzIwMDM4MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-to-participate-in-the-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=739853"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739853\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=739853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=739853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=739853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}